Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Psychopharmacology

Volume 1 Issue 2
ISSN: 2211-5560
eISSN: 2211-5579


   All Titles

  The Role of Oxytocin in Autism Spectrum Disorders
  pp.178-182 (5) Authors: Roberto Canitano, Valeria Scandurra
doi: 10.2174/2211556011201020178

Autism Spectrum Disorders (ASD) are characterized by dysfunction in three core symptom domains: social impairments, communication impairments, and repetitive behaviours with restricted interests. Oxytocin (OXT) and the structurally similar peptide arginine vasopressin (AVP), may play a role in the etiology of these disorders, especially in the social difficulties domain. Oxytocin is involved in milk let-down and uterine contractions at a peripheral level, while in the brain it predominantly has a neuromodulatory function on affiliative and social behavior. Abnormalities of OXT in ASD are herein reviewed, using blood studies, neuroimaging, and translational research. Genetic abnormalities in OXT have also been consistently reported in ASD. Clinical trials with OXT are currently aimed at reducing social impairments and repetitive behaviours. Finally, the current limitations and prospects for the future of OXT treatment in ASD are discussed.

  Keywords: Autism spectrum disorders, social behaviour, oxytocin, arginine vasopressin, translational research, therapeutics, prohormone, endogenous, Vineland Adaptive Behavior Scales, ADP-ribosyl, cyclase activity, neuroimaging, neuromodulatory, arginine vasopressin (AVP), uterine
  Affiliation: Division of Child Neuropsychiatry, University Hospital of Siena, Viale Bracci, 1 53100 Siena, Italy.
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers


  Copyright © 1994 - 2015   Bentham Science Publishers